{"transactions":[{"id":904883,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-13T16:05:06.000Z","date":"2026-02-11","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the options to purchase a total of 35,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 436,010 shares of common stock, which options vest according to their terms."}],"balance_after":35000,"derivative":{"exercise_price":29.7,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001239648-26-000007","document":"form4-02132026_040201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000007/form4-02132026_040201.xml","form_type":"4"}},{"id":904882,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-13T16:05:06.000Z","date":"2026-02-11","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":54,"value":540000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."}],"balance_after":12835,"source":{"system":"sec-edgar","filing":"0001239648-26-000007","document":"form4-02132026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000007/form4-02132026_040201.xml","form_type":"4"}},{"id":904881,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-02-13T16:05:06.000Z","date":"2026-02-11","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":29.7,"value":297000.0,"ownership":{"direct":true},"balance_after":22835,"source":{"system":"sec-edgar","filing":"0001239648-26-000007","document":"form4-02132026_040201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000007/form4-02132026_040201.xml","form_type":"4"}},{"id":941937,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-09T19:13:28.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":5888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":17662,"derivative":{"underlying":"Common Stock","underlying_shares":5888},"source":{"system":"sec-edgar","filing":"0001239648-26-000006","document":"form4-01102026_120125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000006/form4-01102026_120125.xml","form_type":"4"}},{"id":941936,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-09T19:13:28.000Z","date":"2026-01-08","kind":"sale","planned":false,"acquired":false,"shares":2210,"price":44.71,"value":98809.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":12835,"source":{"system":"sec-edgar","filing":"0001239648-26-000006","document":"form4-01102026_120125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000006/form4-01102026_120125.xml","form_type":"4"}},{"id":941935,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-09T19:13:28.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":5888,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":15045,"source":{"system":"sec-edgar","filing":"0001239648-26-000006","document":"form4-01102026_120125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000006/form4-01102026_120125.xml","form_type":"4"}},{"id":943123,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":23200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":23200,"derivative":{"exercise_price":43.91,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":23200},"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":943122,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":17100,"derivative":{"underlying":"Common Stock","underlying_shares":17100},"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":943121,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":false,"shares":5545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":5545,"derivative":{"underlying":"Common Stock","underlying_shares":5545},"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":943120,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":500,"price":47.23,"value":23615.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."}],"balance_after":9157,"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":943119,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":1841,"price":46.1301,"value":84925.5141,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.96 to $46.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9657,"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":943118,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":5281,"price":45.3839,"value":239672.3759,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.87 to $45.835 per share, inclusive. The reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11498,"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":943117,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":2017,"price":45.11,"value":90986.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":16779,"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":943116,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-08T16:12:40.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":true,"shares":5545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":18796,"source":{"system":"sec-edgar","filing":"0001239648-26-000004","document":"form4-01082026_090136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000004/form4-01082026_090136.xml","form_type":"4"}},{"id":946071,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T21:03:25.000Z","date":"2026-01-03","kind":"exercise","planned":false,"acquired":false,"shares":7287,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":14575,"derivative":{"underlying":"Common Stock","underlying_shares":7287},"source":{"system":"sec-edgar","filing":"0001239648-26-000002","document":"form4-01072026_020121.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000002/form4-01072026_020121.xml","form_type":"4"}},{"id":946070,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-06T21:03:25.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":2983,"price":43.26,"value":129044.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":13251,"source":{"system":"sec-edgar","filing":"0001239648-26-000002","document":"form4-01072026_020121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000002/form4-01072026_020121.xml","form_type":"4"}},{"id":946069,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-06T21:03:25.000Z","date":"2026-01-03","kind":"exercise","planned":false,"acquired":true,"shares":7287,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":16234,"source":{"system":"sec-edgar","filing":"0001239648-26-000002","document":"form4-01072026_020121.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964826000002/form4-01072026_020121.xml","form_type":"4"}},{"id":959478,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-23T16:27:33.000Z","date":"2025-12-22","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the options to purchase a total of 43,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 414,810 shares of common stock, which options vest according to their terms."}],"balance_after":43000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001239648-25-000006","document":"form4-12232025_091230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000006/form4-12232025_091230.xml","form_type":"4"}},{"id":959477,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-23T16:27:33.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":51,"value":510000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."}],"balance_after":8947,"source":{"system":"sec-edgar","filing":"0001239648-25-000006","document":"form4-12232025_091230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000006/form4-12232025_091230.xml","form_type":"4"}},{"id":959476,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-23T16:27:33.000Z","date":"2025-12-22","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":14.02,"value":140200.0,"ownership":{"direct":true},"balance_after":18947,"source":{"system":"sec-edgar","filing":"0001239648-25-000006","document":"form4-12232025_091230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000006/form4-12232025_091230.xml","form_type":"4"}},{"id":962997,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"In addition to the options to purchase a total of 53,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 414,810 shares of common stock, which options vest according to their terms."}],"balance_after":53000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962996,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":20.16,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962995,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested."}],"balance_after":63000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962994,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-18","kind":"sale","planned":true,"acquired":false,"shares":141,"price":46.99,"value":6625.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."}],"balance_after":8947,"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962993,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-17","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":46,"value":460000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."}],"balance_after":9088,"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962992,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-17","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":14.02,"value":140200.0,"ownership":{"direct":true},"balance_after":19088,"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962991,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":4195,"price":45.2369,"value":189768.7955,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.13 to $45.34 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":9088,"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962990,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-16","kind":"sale","planned":true,"acquired":false,"shares":8305,"price":44.6756,"value":371030.858,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.12 to $45.11 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13283,"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962989,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":20.16,"value":151200.0,"ownership":{"direct":true},"balance_after":21588,"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":962988,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-12-18T16:14:04.000Z","date":"2025-12-16","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":14.02,"value":70100.0,"ownership":{"direct":true},"balance_after":14088,"source":{"system":"sec-edgar","filing":"0001239648-25-000005","document":"form4-12182025_091200.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000005/form4-12182025_091200.xml","form_type":"4"}},{"id":1029169,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-01T16:00:20.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"In addition to the remaining options to purchase 68,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 422,310 shares of common stock, which options vest according to their terms."}],"balance_after":68000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001239648-25-000004","document":"form4-10012025_081017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000004/form4-10012025_081017.xml","form_type":"4"}},{"id":1029168,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-01T16:00:20.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":8240,"price":29,"value":238960.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025."}],"balance_after":9088,"source":{"system":"sec-edgar","filing":"0001239648-25-000004","document":"form4-10012025_081017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000004/form4-10012025_081017.xml","form_type":"4"}},{"id":1029167,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-01T16:00:20.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":14.02,"value":70100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes the acquisition of 1,325 shares acquired under the Company's ESPP."}],"balance_after":17328,"source":{"system":"sec-edgar","filing":"0001239648-25-000004","document":"form4-10012025_081017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000123964825000004/form4-10012025_081017.xml","form_type":"4"}},{"id":1307828,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option vests as to 25% of the total shares on January 7, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":67000,"derivative":{"exercise_price":14.83,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1307827,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":23550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":23550,"derivative":{"underlying":"Common Stock","underlying_shares":23550},"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1307826,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-06","kind":"exercise","planned":false,"acquired":false,"shares":5545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":11090,"derivative":{"underlying":"Common Stock","underlying_shares":5545},"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1307825,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":false,"shares":7288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":21862,"derivative":{"underlying":"Common Stock","underlying_shares":7288},"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1307824,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":2217,"price":15.3,"value":33920.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes."}],"balance_after":11003,"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1307823,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-06","kind":"exercise","planned":false,"acquired":true,"shares":5545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":13220,"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1307822,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":2994,"price":14.6,"value":43712.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy a portion of the tax withholding obligation in connection with the vesting of RSUs and do not represent discretionary transactions by the Reporting Person. Following the transactions reflecting in this Form 4, no additional transactions are expected to satisfy the Reporting Person's tax withholding obligation."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Reporting Person did not sell or otherwise dispose of any of the shares with respect to the vesting of RSUs reported on this Form 4 for any reason other than to cover required taxes."}],"balance_after":7675,"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1307821,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-07T17:32:09.000Z","date":"2025-01-03","kind":"exercise","planned":false,"acquired":true,"shares":7288,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the acquisition of 141 shares acquired under the Company's ESPP."}],"balance_after":10669,"source":{"system":"sec-edgar","filing":"0001415889-25-001042","document":"form4-01072025_100105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588925001042/form4-01072025_100105.xml","form_type":"4"}},{"id":1404887,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-17T18:44:23.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"In addition to the remaining options to purchase 73,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 355,310 shares of common stock, which options vest according to their terms."}],"balance_after":73000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-023551","document":"form4-09172024_100920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924023551/form4-09172024_100920.xml","form_type":"4"}},{"id":1404886,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-09-17T18:44:23.000Z","date":"2024-09-14","kind":"exercise","planned":true,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001415889-24-023551","document":"form4-09172024_100920.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924023551/form4-09172024_100920.xml","form_type":"4"}},{"id":1404885,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T18:44:23.000Z","date":"2024-09-17","kind":"sale","planned":true,"acquired":false,"shares":3780,"price":38.4103,"value":145190.934,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3240,"source":{"system":"sec-edgar","filing":"0001415889-24-023551","document":"form4-09172024_100920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924023551/form4-09172024_100920.xml","form_type":"4"}},{"id":1404884,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T18:44:23.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":6500,"price":40.13,"value":260845.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated June 10, 2024."}],"balance_after":7020,"source":{"system":"sec-edgar","filing":"0001415889-24-023551","document":"form4-09172024_100920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924023551/form4-09172024_100920.xml","form_type":"4"}},{"id":1404883,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T18:44:23.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":14.02,"value":70100.0,"ownership":{"direct":true},"balance_after":13520,"source":{"system":"sec-edgar","filing":"0001415889-24-023551","document":"form4-09172024_100920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924023551/form4-09172024_100920.xml","form_type":"4"}},{"id":1404882,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T18:44:23.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":2220,"price":38.93,"value":86424.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":8520,"source":{"system":"sec-edgar","filing":"0001415889-24-023551","document":"form4-09172024_100920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924023551/form4-09172024_100920.xml","form_type":"4"}},{"id":1404881,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-09-17T18:44:23.000Z","date":"2024-09-14","kind":"exercise","planned":true,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,500 shares acquired under the Employee Stock Purchase Plan as of May 15, 2024."}],"balance_after":10740,"source":{"system":"sec-edgar","filing":"0001415889-24-023551","document":"form4-09172024_100920.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924023551/form4-09172024_100920.xml","form_type":"4"}},{"id":1449277,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-24T16:13:52.000Z","date":"2024-07-22","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance stock unit (\"PSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics (\"Performance Metrics\"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026.  An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Shares earned upon the vesting of a percentage of the PSUs granted to the Reporting Person on July 22, 2024. Each PSU represents a contingent right to receive one share of Issuer common stock upon the Issuer's achievement of certain share price metrics (\"Performance Metrics\"). 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the later of (i) the 1-year anniversary of the achievement of such applicable Performance Metrics and (ii) on July 1, 2026.  An additional 50% of the total number of shares subject to the PSU that achieves the applicable Performance Metrics shall vest on the 2-year anniversary of such achievement (but not later than July 1, 2028), subject to the Reporting Person' service to the Issue on each vesting date."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-020031","document":"form4-07242024_080748.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924020031/form4-07242024_080748.xml","form_type":"4"}},{"id":1628527,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-21T17:38:06.000Z","date":"2024-02-16","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 78,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 355,310 shares of common stock, which options vest according to their terms."}],"balance_after":78000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-004666","document":"form4-02212024_100259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924004666/form4-02212024_100259.xml","form_type":"4"}},{"id":1628526,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-21T17:38:06.000Z","date":"2024-02-16","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":25,"value":125000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated September 15, 2023."}],"balance_after":3240,"source":{"system":"sec-edgar","filing":"0001415889-24-004666","document":"form4-02212024_100259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924004666/form4-02212024_100259.xml","form_type":"4"}},{"id":1628525,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF LEGAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-21T17:38:06.000Z","date":"2024-02-16","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":14.02,"value":70100.0,"ownership":{"direct":true},"balance_after":8240,"source":{"system":"sec-edgar","filing":"0001415889-24-004666","document":"form4-02212024_100259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000141588924004666/form4-02212024_100259.xml","form_type":"4"}},{"id":1682529,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-09T19:07:18.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":false,"shares":5545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":16635,"derivative":{"underlying":"Common Stock","underlying_shares":5545},"source":{"system":"sec-edgar","filing":"0001209191-24-001279","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919124001279/doc4.xml","form_type":"4"}},{"id":1682528,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-09T19:07:18.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":2305,"price":21.81,"value":50272.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":3240,"source":{"system":"sec-edgar","filing":"0001209191-24-001279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919124001279/doc4.xml","form_type":"4"}},{"id":1682527,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-01-09T19:07:18.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":true,"shares":5545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":5545,"source":{"system":"sec-edgar","filing":"0001209191-24-001279","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919124001279/doc4.xml","form_type":"4"}},{"id":1685346,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-05T16:55:26.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":29150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":29150,"derivative":{"underlying":"Common Stock","underlying_shares":29150},"source":{"system":"sec-edgar","filing":"0001209191-24-001047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919124001047/doc4.xml","form_type":"4"}},{"id":1685345,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T16:55:26.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":79780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on January 3, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":79780,"derivative":{"exercise_price":21.19,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":79780},"source":{"system":"sec-edgar","filing":"0001209191-24-001047","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919124001047/doc4.xml","form_type":"4"}},{"id":1729435,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-11-27T16:03:40.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":882,"price":14.19,"value":12515.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated September 29, 2022, as amended February 21, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares sold represent 882 shares purchased pursuant to the Company's ESPP at 85% of the lesser of the closing price of the Issuer's Common Stock on November 16, 2022 and the closing price of May 15, 2023."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-056638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919123056638/doc4.xml","form_type":"4"}},{"id":1778735,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-09-18T18:13:51.000Z","date":"2023-09-14","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-23-049809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919123049809/doc4.xml","form_type":"4"}},{"id":1778734,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-09-18T18:13:51.000Z","date":"2023-09-18","kind":"sale","planned":false,"acquired":false,"shares":3895,"price":19.3151,"value":75232.3145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.135 to $19.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":882,"source":{"system":"sec-edgar","filing":"0001209191-23-049809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919123049809/doc4.xml","form_type":"4"}},{"id":1778733,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-09-18T18:13:51.000Z","date":"2023-09-14","kind":"sale","planned":false,"acquired":false,"shares":2105,"price":19.48,"value":41005.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":4777,"source":{"system":"sec-edgar","filing":"0001209191-23-049809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919123049809/doc4.xml","form_type":"4"}},{"id":1778732,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2023-09-18T18:13:51.000Z","date":"2023-09-14","kind":"exercise","planned":false,"acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects the acquisition of 882 shares acquired under the Company's ESPP."}],"balance_after":6882,"source":{"system":"sec-edgar","filing":"0001209191-23-049809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919123049809/doc4.xml","form_type":"4"}},{"id":2057374,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2023-01-10T19:08:23.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":22180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":22180,"derivative":{"underlying":"Common Stock","underlying_shares":22180},"source":{"system":"sec-edgar","filing":"0001209191-23-002881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919123002881/doc4.xml","form_type":"4"}},{"id":2057373,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-10T19:08:23.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":60530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on January 6, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":60530,"derivative":{"exercise_price":23.23,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":60530},"source":{"system":"sec-edgar","filing":"0001209191-23-002881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919123002881/doc4.xml","form_type":"4"}},{"id":2157173,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Restricted Stock Unit","published_at":"2022-09-16T17:07:41.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents a one-time retention grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the total RSUs vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"50% of the total RSUs vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 12,000 shares of common stock as set forth in Table II above, the Reporting Person also holds an additional options to purchase up to an aggregate of 308,000 shares of common stock, which options vest according to their terms."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-050351","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122050351/doc4.xml","form_type":"4"}},{"id":2190647,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-09T18:03:15.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":523,"price":25,"value":13075.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares sold represent 523 shares purchased pursuant to the Company's ESPP at 85% of the lesser of the closing price of the Issuer's Common Stock on November 15, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-045061","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122045061/doc4.xml","form_type":"4"}},{"id":2221027,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T19:04:47.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 10, 2021, the reporting person was granted a performance-based option to purchase 10,000 shares of the Issuer's common stock, subject to the achievement of certain corporate performance criteria and the reporting person's continued service to the Issuer upon achievement thereof.  The performance criteria were achieved on the date in Column 3, resulting in the vesting of the entire award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 10,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 298,000 shares of common stock, which options vest according to their terms, and (ii) 523 shares of common stock held directly."}],"balance_after":10000,"derivative":{"exercise_price":29.7,"exercise_date":"2022-06-23","expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-039532","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122039532/doc4.xml","form_type":"4"}},{"id":2235687,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-10T17:22:37.000Z","date":"2022-06-08","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 83,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 215,000 shares of common stock, which options vest according to their terms."}],"balance_after":83000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-22-036020","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122036020/doc4.xml","form_type":"4"}},{"id":2235686,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T17:22:37.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":2500,"price":24,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":523,"source":{"system":"sec-edgar","filing":"0001209191-22-036020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122036020/doc4.xml","form_type":"4"}},{"id":2235685,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2022-06-10T17:22:37.000Z","date":"2022-06-08","kind":"exercise","acquired":true,"shares":2500,"price":14.02,"value":35050.0,"ownership":{"direct":true},"balance_after":3023,"source":{"system":"sec-edgar","filing":"0001209191-22-036020","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122036020/doc4.xml","form_type":"4"}},{"id":2261583,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-20T16:42:00.000Z","date":"2022-05-18","kind":"sale","acquired":false,"shares":1146,"price":20.5,"value":23493.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares sold represent 1,146 shares purchased pursuant to the Company's ESPP at 85% of the lesser of the closing price of the Issuer's Common Stock on May 13, 2022 and November 16, 2022."}],"balance_after":523,"source":{"system":"sec-edgar","filing":"0001209191-22-031028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122031028/doc4.xml","form_type":"4"}},{"id":2397548,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-14T16:47:19.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2023, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 70,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 230,500 shares of common stock, which options vest according to their terms, and (ii) 523 shares of common stock held directly."}],"balance_after":70000,"derivative":{"exercise_price":30.44,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-22-009335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919122009335/doc4.xml","form_type":"4"}},{"id":2506692,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2021-11-17T17:18:45.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":523,"price":22.03,"value":11521.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock acquired pursuant to the Issuer's Employee Stock Purchase Plan (\"ESPP\"), for the purchase period through November 15, 2021. In accordance with the ESPP, these shares were purchased at 85% of the lesser of the closing price of the Issuer's Common Stock on May 17, 2021 and November 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the reporting person's common stock directly held as set forth in Table I above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 230,500 shares of common stock, which options vest according to their terms."}],"balance_after":523,"source":{"system":"sec-edgar","filing":"0001209191-21-065168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121065168/doc4.xml","form_type":"4"}},{"id":2522713,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-05T18:23:19.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vested and is exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms."}],"balance_after":7500,"derivative":{"exercise_price":20.16,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-063260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121063260/doc4.xml","form_type":"4"}},{"id":2522712,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-05T18:23:19.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 93,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 137,500 shares of common stock, which options vest according to their terms."}],"balance_after":85500,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001209191-21-063260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121063260/doc4.xml","form_type":"4"}},{"id":2522711,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2021-11-05T18:23:19.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":5000,"price":35,"value":175000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-063260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121063260/doc4.xml","form_type":"4"}},{"id":2522710,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2021-11-05T18:23:19.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":2500,"price":20.16,"value":50400.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-21-063260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121063260/doc4.xml","form_type":"4"}},{"id":2522709,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2021-11-05T18:23:19.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":2500,"price":14.02,"value":35050.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-21-063260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121063260/doc4.xml","form_type":"4"}},{"id":2862795,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-12T21:28:43.000Z","date":"2021-02-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"In addition to the remaining option to purchase 88,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 147,500 shares of common stock, which options vest according to their terms."}],"balance_after":88000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-010517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121010517/doc4.xml","form_type":"4"}},{"id":2862794,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-12T21:28:43.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":45000,"derivative":{"exercise_price":29.7,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-21-010517","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121010517/doc4.xml","form_type":"4"}},{"id":2862793,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2021-02-12T21:28:43.000Z","date":"2021-02-12","kind":"sale","acquired":false,"shares":10000,"price":35,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 were effected pursuant to a Rule 105b-1 trading plan adopted by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-21-010517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121010517/doc4.xml","form_type":"4"}},{"id":2862792,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Common Stock","published_at":"2021-02-12T21:28:43.000Z","date":"2021-02-12","kind":"exercise","acquired":true,"shares":10000,"price":14.02,"value":140200.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-010517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919121010517/doc4.xml","form_type":"4"}},{"id":3082525,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO, General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-07-15T17:06:39.000Z","date":"2020-07-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on July 15, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":20.16,"expiration_date":"2030-07-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-042506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919120042506/doc4.xml","form_type":"4"}},{"id":3346427,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Interim CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-10T17:40:06.000Z","date":"2019-12-06","kind":"grant","acquired":true,"shares":98000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":98000,"derivative":{"exercise_price":14.02,"expiration_date":"2029-12-05","underlying":"Common Stock","underlying_shares":98000},"source":{"system":"sec-edgar","filing":"0001209191-19-059924","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919119059924/doc4.xml","form_type":"4"}},{"id":3433146,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Interim CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-08-20T17:04:25.000Z","date":"2019-08-18","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 4 year period: 25% vest and become exercisable on August 18, 2020, after which 1/48th of the total shares vest and become exercisable monthly thereafter, subject to reporting person's continuous service through each vesting date."}],"balance_after":17500,"derivative":{"exercise_price":49.2,"expiration_date":"2029-08-17","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-19-046820","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919119046820/doc4.xml","form_type":"4"}},{"id":3665655,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-11T17:30:31.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 8, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":35000,"derivative":{"exercise_price":68.89,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-19-009028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919119009028/doc4.xml","form_type":"4"}},{"id":3849550,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-08T17:56:36.000Z","date":"2018-08-06","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 4 year period: 25% vest and become exercisable on August 6, 2019, after which 1/48th of the total shares vest and become exercisable monthly thereafter, subject to reporting person's continuous service through each vesting date."}],"balance_after":40000,"derivative":{"exercise_price":78.18,"expiration_date":"2028-08-05","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-18-045892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239648/000120919118045892/doc4.xml","form_type":"4"}},{"id":4076322,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-02-05T17:38:10.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4) of the shares subject to the option vest on February 1, 2019 and one forty-eighth (1/48) of the shares vest monthly thereafter."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the options acquired as set forth in Table II, the Reporting Person currently holds options to purchase up to an aggregate of\n146,665 shares of common stock, which options vest according to their terms."}],"balance_after":110000,"derivative":{"exercise_price":5.8,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001209191-18-007610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919118007610/doc4.xml","form_type":"4"}},{"id":4092363,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-23T17:34:18.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":33333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On January 19, 2018, in connection with the Issuer's option exchange program, the Issuer cancelled an option for 50,000 shares of common stock granted to the Reporting Person on March 6, 2017. In exchange, the Reporting Person received an option grant for 33,333 shares of common stock with exercise price of $5.675 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Of the 33,333 total shares subject to the option, 11,111 shares vest on January 19, 2019. Of the remaining 22,222 shares subject to the option, one-third\n(1/3) of these shares vest on January 19, 2019, and one thirty-sixth (1/36) of these shares vest monthly thereafter."}],"balance_after":33333,"derivative":{"exercise_price":5.675,"expiration_date":"2026-01-18","underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001209191-18-004965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919118004965/doc4.xml","form_type":"4"}},{"id":4092362,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-23T17:34:18.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":46666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On January 19, 2018, in connection with the Issuer's option exchange program, the Issuer cancelled an option for 70,000 shares of common stock granted to the Reporting Person on March 1, 2016. In exchange, the Reporting Person received an option grant for 46,666 shares of common stock with exercise price of $5.675 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Of the 46,666 total shares subject to the option, 27,222 shares vest on January 19, 2019. Of the remaining 19,444 shares subject to the option, one-third\n(1/3) of these shares vest on January 19, 2019, and one thirty-sixth (1/36) of these shares vest monthly thereafter."}],"balance_after":46666,"derivative":{"exercise_price":5.675,"expiration_date":"2026-01-18","underlying":"Common Stock","underlying_shares":46666},"source":{"system":"sec-edgar","filing":"0001209191-18-004965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919118004965/doc4.xml","form_type":"4"}},{"id":4092361,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-23T17:34:18.000Z","date":"2018-01-19","kind":"grant","acquired":true,"shares":66666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2018, in connection with the Issuer's option exchange program, the Issuer cancelled an option for 100,000 shares of common stock granted to the Reporting Person on May 15, 2015. In exchange, the Reporting Person received an option grant for 66,666 shares of common stock with exercise price of $5.675 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Of the 66,666 total shares subject to the option, 52,777 shares vest on January 19, 2019. Of the remaining 13,889 shares subject to the option, one-third\n(1/3) of these shares vest on January 19, 2019, and one thirty-sixth (1/36) of these shares vest monthly thereafter."}],"balance_after":66666,"derivative":{"exercise_price":5.675,"expiration_date":"2026-01-18","underlying":"Common Stock","underlying_shares":66666},"source":{"system":"sec-edgar","filing":"0001209191-18-004965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919118004965/doc4.xml","form_type":"4"}},{"id":4092360,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-23T17:34:18.000Z","date":"2018-01-19","kind":"disposition_to_issuer","acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On January 19, 2018, in connection with the Issuer's option exchange program, the Issuer cancelled an option for 50,000 shares of common stock granted to the Reporting Person on March 6, 2017. In exchange, the Reporting Person received an option grant for 33,333 shares of common stock with exercise price of $5.675 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-fourth (1/4) of the shares subject to the option vest on March 6, 2018 and one forty-eighth (1/48) of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":14,"expiration_date":"2027-03-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-18-004965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919118004965/doc4.xml","form_type":"4"}},{"id":4092359,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-23T17:34:18.000Z","date":"2018-01-19","kind":"disposition_to_issuer","acquired":false,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On January 19, 2018, in connection with the Issuer's option exchange program, the Issuer cancelled an option for 70,000 shares of common stock granted to the Reporting Person on March 1, 2016. In exchange, the Reporting Person received an option grant for 46,666 shares of common stock with exercise price of $5.675 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-fourth (1/4) of the shares subject to the option vest on March 1, 2017 and one forty-eighth (1/48) of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":14.44,"expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-18-004965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919118004965/doc4.xml","form_type":"4"}},{"id":4092358,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-23T17:34:18.000Z","date":"2018-01-19","kind":"disposition_to_issuer","acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 19, 2018, in connection with the Issuer's option exchange program, the Issuer cancelled an option for 100,000 shares of common stock granted to the Reporting Person on May 15, 2015. In exchange, the Reporting Person received an option grant for 66,666 shares of common stock with exercise price of $5.675 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth (1/4) of the total number of shares initially subject to the option vest on May 15, 2016, and one forty-eighth (1/48) of the shares vest monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":31.59,"expiration_date":"2025-05-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-18-004965","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919118004965/doc4.xml","form_type":"4"}},{"id":4271747,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-06-27T17:09:39.000Z","date":"2017-06-26","kind":"sale","acquired":false,"shares":1206,"price":18.75,"value":22612.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-17-041981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919117041981/doc4.xml","form_type":"4"}},{"id":4271746,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-06-27T17:09:39.000Z","date":"2017-06-23","kind":"sale","acquired":false,"shares":2316,"price":18.5,"value":42846.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":1206,"source":{"system":"sec-edgar","filing":"0001209191-17-041981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919117041981/doc4.xml","form_type":"4"}},{"id":4271745,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-06-27T17:09:39.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":1206,"price":11.43,"value":13784.58,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":3522,"source":{"system":"sec-edgar","filing":"0001209191-17-041981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919117041981/doc4.xml","form_type":"4"}},{"id":4271744,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-06-27T17:09:39.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":647,"price":13.05,"value":8443.35,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":2316,"source":{"system":"sec-edgar","filing":"0001209191-17-041981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919117041981/doc4.xml","form_type":"4"}},{"id":4271743,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-06-27T17:09:39.000Z","date":"2016-06-01","kind":"grant","acquired":true,"shares":1021,"price":13.13,"value":13405.73,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":1669,"source":{"system":"sec-edgar","filing":"0001209191-17-041981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919117041981/doc4.xml","form_type":"4"}},{"id":4271742,"issuer":{"id":116495,"kind":"organization","name":"OTONOMY, INC.","symbol":"OTIC"},"owners":[{"id":66472,"kind":"person","name":"LOUMEAU ERIC J","position":1,"cik":"0001239648","reported_name":"LOUMEAU ERIC J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GC & Chief Compliance Officer"}}],"security":"Common Stock","published_at":"2017-06-27T17:09:39.000Z","date":"2015-12-01","kind":"grant","acquired":true,"shares":648,"price":20.37,"value":13199.76,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Acquired pursuant to the Issuer's 2014 Employee Stock Purchase Plan."}],"balance_after":648,"source":{"system":"sec-edgar","filing":"0001209191-17-041981","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1493566/000120919117041981/doc4.xml","form_type":"4"}}],"next_cursor":"2017-06-27T17:09:39.000000Z,4271742"}